Who
Aimee S. Weisner
Director
Company insider
Files Form 4 as: Director, Lensar; Director, Glaukos; Director, STAAR Surgical; Director, Oyster Point Pharma; CVP, General Counsel, Edwards Lifesciences; Executive Vice President, Abbott Medical Optics.
In numbers
- Trades disclosed
- 135
- Buys
- 8
- Sells
- 3
- Bought
- $390K
- Sold
- $6.6M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 24 May 2006
- Last trade
- 3 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —17,421 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —17,421 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —980 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —980 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $249K2,153 at $115.69 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $611K5,242 at $116.64 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $133K1,134 at $117.33 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $767K6,471 at $118.56 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —980 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —980 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
News
Glaukos Expands Retinal Pipeline With RevOpsis Deal - Orange County Business JournalGKOS · ocbj.com · 19 Oct 2026Glaukos: IDose TR Plus Cataract Surgery Delivers Superior Eye Pressure Reduction In Phase 4 TrialGKOS · rttnews.com · 9 Oct 2026
0 headlines in the last 90 days name Aimee S. Weisner; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.